TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company

Transcenta, biologics, antibody

TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company


Director, Business Development

Department :  10
Working place :  US
Recruitment :  1
Nature of work :  Full-Time
Working years of :  5+ year experience
Minimum academic :  PhD
Release time :  25 Sep, 2020
Job Description
  • The Director of Business Development will lead business development activities that support Transcenta’s overall strategy and corporate objectives. This individual will be responsible for identification and evaluation of business opportunities (including technology platforms), managing in/out-bound transactions including licensing transactions, strategy partnership, research collaborations, co-development, and maintenance of relationship with business partners including alliance management

  • Work with senior management and internal stakeholders to identify opportunities to maximize the value of internal assets, enhance pipeline and build strong technology platform

  • Collaborate with cross functional teams including R&D, Finance, and/or legal to perform technology and commercial assessments (including market landscape and competitive intelligence), build valuation models, and conduct benchmark analysis to support deal structuring and partnership discussion

  • Prepare and maintain internal and external BD related presentations (including financial/deal analyses, corporate or program presentations, opportunity assessments, etc.)

  • Manage business relationships with business partners, and play a critical role across key BD activities such as response to BD inquiries, attending industry conferences, presenting pitch decks, managing on-going BD communication, leading due diligence and transactions

  • Coordinate and participate in due diligence processes; Maintains and organizes data rooms

  • Organize, track, document and report the status of business development projects

  • Monitor key industry trend and competitive landscape

  • Build network with key academic institutions, biotech and pharmaceutical companies and investment communities

  • Establish collaborative relationships and maintain close communication with the senior management team and other key internal stakeholders to ensure alignment on current projects

  • Travel : 30% travel required, including internationally

  • Professional Qualifications:

  • PhD in biological sciences is required; PhD with MBA is preferred.

  • Knowledge and experience in oncology, immunology and/or cell biology preferred.

  • 5+ year experience in biotech, pharmaceutical, medical device, business consultant, or investment banking, with working knowledge in business development, corporate strategy, finance, and/or commercial planning.

  • Good working knowledge in drug development and commercialization process (Research, Product Development, Manufacturing, IP, Commercialization)

  • Comparable combinations of education and experience will be considered

  • Personal Skills:

  • Strong qualitative and quantitative analytical skills with attention to details

  • Effective written and verbal communication skills, including executive presence and ability to interact with external parties.

  • Strong negotiation and partnering skills, including ability to influence and drive results across functions and levels.

  • Strong project management capabilities and focus on delivery of results based on agreed timelines.

  • Self-motivated and possesses a sense of urgency, identifies issues/challenges and takes initiative to identify solutions.

  • Excellent organization skill

  • Key Requirements:

  • Scientific background is preferred

  • High potential to learn

  • Business Analysis (competence can be trained; interest is priority)

  • Technical evaluation experience is more preferred rather than License-in & out basic work experience

  • English competence

  • Work location: flexible in USA (home base), can develop projects, communicate with partners & internal stakeholders

  • Big company BD limited on process may not be suitable

  • No request to cover other countries